Hanmi Pharm. Co., Ltd. (128940.KS) on Thursday reported higher first-quarter profit, while revenue was broadly stable.
Net income from continuing operation before income tax rose to 55.380 billion won from 53.177 billion won in the same period last year.
Operating income declined to 53.649 billion won from 59.020 billion won a year earlier.
Net income attributable to shareholders of the parent company increased to 45.490 billion won from 42.606 billion won in the prior-year period.
Sales were 392.926 billion won, 0.5% up from 390.948 billion won a year earlier.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.